Borderline Resectable Carcinoma Clinical Trials in Shantou, Guangdong

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma